IPOs & Public Markets on Pulse — Page 12

Tech IPOs, public-market debuts, and what each one means for the exit environment.

665
Stories
366
With a headline figure
Oct 5, 2026
Latest

Older Coverage

stories 661–665 of 665
IPO

OpenAI and Anthropic File Confidential S-1s -- IPOs Expected 2026

OpenAI and Anthropic File Confidential S-1s -- IPOs Expected 2026 logo
IPO

OpenAI and Anthropic File Confidential S-1s -- IPOs Expected 2026

The two most valuable private AI companies -- OpenAI at ~$852B, Anthropic at ~$965B -- have both filed confidentially with the SEC. When they list, all six MANGOS companies will be public.

IPO

Research Alliance Files for Its Fourth Healthcare SPAC

Illustration for: Research Alliance Files for Its Fourth Healthcare SPAC
IPO

Research Alliance Files for Its Fourth Healthcare SPAC

Research Alliance Corp IV filed for a $75 million IPO of 7.5 million Class A shares, the fourth blank-check company from a sponsor group that has repeatedly targeted healthcare-sector reverse mergers.

IPO

Matternet Becomes First Pure-Play Drone Delivery Company to Go Public

Illustration for: Matternet Becomes First Pure-Play Drone Delivery Company to Go Public
IPO$33M raised

Matternet Becomes First Pure-Play Drone Delivery Company to Go Public

Matternet, the FAA type-certified drone delivery platform, completed a reverse merger to go public and raised $33 million in a private placement alongside the transaction, closing May 22 and making it the first publicly reporting company focused exclusively on drone delivery. CEO Andreas Raptopoulos framed 2026 as the inflection point for U.S. drone delivery as the company expands across healthcare, retail and restaurant delivery.

IPO

HCW Biologics Files S-1 for Small $5.6M Best-Efforts Raise

Illustration for: HCW Biologics Files S-1 for Small $5.6M Best-Efforts Raise
IPO

HCW Biologics Files S-1 for Small $5.6M Best-Efforts Raise

HCW Biologics filed an S-1 for a best-efforts offering of up to $5.6 million, a modest raise reflecting the tighter capital-access conditions many small-cap clinical-stage biotechs still face despite the broader 2026 IPO boom.

IPO

Cerebras (CBRS) Continues Hot Streak -- Up 68% Since May IPO

Cerebras (CBRS) Continues Hot Streak -- Up 68% Since May IPO logo
IPO$3.5B raise

Cerebras (CBRS) Continues Hot Streak -- Up 68% Since May IPO

Cerebras is the market's clearest bet on AI hardware scarcity -- up 68% since its May debut at $312. The AI chipmaker trades at a premium pricing in years of Nvidia-alternative demand.